Page 14 - Flow Through Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Edison Cobalt Corp.: Edison Closes Private Placements Edison Cobalt Corp (TSXV: the " Company") is pleased to announce it has closed the previously announced (see news release 04-30-2021) non-brokered private placements of 2,006,000 flow-through units (the " FT Units") at a price of $0.18 per Flow-Through Unit, for gross proceeds of $361,080 and 19,878,000 non-flow-through units (the "non FT Units") at a price of $0.135 per Unit, for gross proceeds of $2,683,530. Each FT unit consisted of one common share and one warrant. Each warrant entitles the holder to acquire one common share of the ...

the “ Company“)  is pleased to announce it has closed the previously announced (see news release 04-30-2021) non-brokered private placements of 2,006,000 flow-through units (the “ FT Units“) at a price of $0.18 per Flow-Through Unit, for gross proceeds of $361,080 and 19,878,000 non-flow-through units (the “non FT Units”) at a price of $0.135 per Unit, for gross proceeds of $2,683,530. We apologize, but this video has failed to load. Try refreshing your browser. Edison Closes Private Placements Back to video Each FT unit consisted of one common share and one warrant. Each war...

- MultiXthin – For Flouroscopy market Voyageur is prepared to test its newly-formulated products under GMP and HC guidelines and advance to clinical testing. Voyageur plans to ensure that it is creating the highest quality products prior to phase one marketing, sales and distribution to Canadian, USA and international markets. Voyageur has begun the process to prepare applications for FDA device registrations. Based on the new regulatory change of barium sulfate being designated as a device, versus its previous designation as a drug, Voyageur plans to move forward with a marketing and sal...

Voyageur Pharmaceuticals Ltd. Issued 4th Health Canada License For Radiographic Barium Contrast Product Brand Story Voyageur Pharmaceuticals Ltd. ( TSX.V:VM) ( OTC:VYYRF) (the 'Company' or 'Voyageur') is pleased to announce that it has received approval from Health Canada (HC) for its product, MultiXthin barium sulfate suspension. MultiXthin is specifically designed for single contrast radiographic examinations of the oesophagus, stomach, and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients. Voyageur has built a suite of barium radiographic contrast me...

Genius Metals Completes a $700K First Tranche of Financing, Secures a Diamond-Drilling Contract for Sakami and Extends the Exercise Period of Outstanding Warrants Genius Metals Inc. completed a first tranche of a non-brokered private placement offering for gross proceeds of $707,898 . The Corporation intends to focus on developing the Sakami property with the proceeds raised as part of this private placement. Also, the Corporation is pleased … CSE:GENI /NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES/ MONTRÉAL, May 4, 2021 /CNW Telbec/ – Gen...